Intelligence Platform

Patents

Browse 763 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6224866

Immunotherapy of B cell involvement in progression of solid, nonlymphoid tumors

BioCrystal, Ltd. · Granted Tue May 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6207147

Cancer immunotherapy using tumor cells combined with mixed lymphocytes

The Regents of the University of California · Granted Tue Mar 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6204000

Diagnostic methods and gene therapy using reagents derived from the human metastasis suppr

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6190656

Immunologic enhancement with intermittent interleukin-2 therapy

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6183752

Restenosis/atherosclerosis diagnosis, prophylaxis and therapy

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6180142

Reduction of surfactant inactivation in pulmonary surfactant therapy

The Regents of the University of California · Granted Tue Jan 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6103694

Method of decreasing radiation of radio-mimetic chemotherapy for hematopoietic pluripotent

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 15 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6090365

Radioimmunotherapy of lymphoma using anti-CD20 antibodies

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6084069

Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6051218

Tumor radiosensitization using gene therapy

The Regents of the University of California · Granted Tue Apr 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6045789

Bystander effect tumoricidal therapy by expressing an HSV-tk gene

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Apr 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6042829

Biotherapy of cancer by targeting TP-3/P80

Regents of the University of Minnesota · Granted Tue Mar 28 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6040334

Use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase as a modality in canc

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6037376

Methods for therapy of cancer

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 14 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6037337

Use of the enantiomers of ifosfamide in antitumor therapy for reducing side effects

Darwin Discovery Limited · Granted Tue Mar 14 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6033688

Cystic fibrosis therapy

The Regents of the University of California · Granted Tue Mar 07 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6015542

Radioimmunotherapy of lymphoma using anti-CD20 antibodies

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6011001

Method of protein therapy by orally administering crosslinked protein crystals

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6010908

Gene therapy by small fragment homologous replacement

The Regents of the University of California · Granted Tue Jan 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

expired